We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Call for Research

The Food Standards Agency is commissioning a number of surveys of microbiological and chemical contaminants in food, as well as a trial of visual post-mortem inspections in pigs, and a study to investigate the effect of processing on pesticide residues in food.
News

Determination of Cyanuric Acid in Milk Powder by Anion-Exchange Chromatography

This article details how researchers have developed an anion-exchange chromatographic method for simultaneous analysis of cyanuric acid and five inorganic anions in milk powder.
News

Oncolytics Biotech® Inc. Announces First Quarter 2011 Results

Oncolytics has announced financial results and operational highlights for the quarter ended March 31, 2011.
News

Structure-Activity Relationship of New Anti-Tuberculosis Agents Derived from Oxazoline and Oxazole Benzyl Esters

Researchers from the University of Notre Dame have prepared a number of compounds that were shown to possess impressive activity against Mycobacterium tuberculosis, extremely low toxicity and therefore high therapeutic indexes.
News

UT Southwestern Researchers Find Protein that Might be Key to Cutting Cancer Cells’ Blood Supply

Researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.
News

Structure Based Drug Designing of a Novel Antiflaviviral Inhibitor for Nonstructural 3 Protein

Researchers have employed molecular docking methodology to explore the NS3 protein's catalytic triad to find out the critical interactions pattern for inhibitor binding.
News

RXi Pharmaceuticals Completes Apthera Acquisition

The acquisition provides RXi with a late stage product candidate, NeuVax™, a peptide-based immunotherapy for low-to-intermediate HER2+ breast cancer, patients who are not eligible for Herceptin® RXi has targeted NeuVax to enter Phase III clinical trials in the first half of 2012.
News

Kantar Health France Names Catherine Verneuil Deputy Head of Oncology Department

Ms. Verneuil will implement the new Oncology Department organizational structure and focus on team management and project profitability.
News

Astellas Pharma and BioFocus Sign Target Discovery Agreement

Collaboration agreement with Astellas focused on discovering novel targets in the field of CNS disorders.
News

Prexa Pharmaceuticals Obtains $7.0 Million in Series B Financing

Funds to bring lead CNS product candidate through Phase 1b studies.
Advertisement